Myostatin as a Biomarker for Diagnosis or Prognosis of Frailty and Sarcopenia: Current Knowledge
Gerontology
.
2019;65(4):385-386.
doi: 10.1159/000496469.
Epub 2019 Mar 1.
Authors
Haritz Arrieta
1
,
Ana Rodriguez-Larrad
2
,
Jon Irazusta
2
Affiliations
1
Department of Physiology, Faculty of Medicine and Nursing, University of the Basque Country (UPV/EHU), Leioa, Spain, haritz.arrieta@ehu.eus.
2
Department of Physiology, Faculty of Medicine and Nursing, University of the Basque Country (UPV/EHU), Leioa, Spain.
PMID:
30820018
DOI:
10.1159/000496469
No abstract available
Publication types
Letter
Research Support, Non-U.S. Gov't
Comment
MeSH terms
Biomarkers
Exercise Therapy
Frailty*
Humans
Myostatin
Nursing Homes
Prognosis
Sarcopenia*
Substances
Biomarkers
Myostatin